Executive Medical Director, Clinical Development, Hematology, Nephrology Transplant, Cell Therapy

The Executive Medical Directo
r (EMD) role is generally assigned to be responsible for overseeing 2 or more programs, providing oversight/guidance/mentoring to the Medical Directors and Clinical Development Scientists on the teams, serving on cross-asset strategic teams (e.g., disease strategy team) and providing input to strategic decisions at the TA Strategy Team and Global Medicine Team meetings.

Generally, the role may include managerial responsibilities over Senior Director, Medical Director Clinical Development directly and may support / oversee other Medical Directors/Clinical Development Scientists that report indirectly to the Executive Medical Director. The EMD may support development of regulatory strategy, therapeutic area and other functional strategies.

The EMD is a specialized role and is specifically designated to provide medical leadership and input to Program Teams during the early to late stage of drug development (i.e., transitioning molecule through IND/CTA and First-in-Human study stage to Proof-of-Concept and End-of-Phase-2 stage and beyond). The incumbent will serve as one of the medical experts for the study team(s) and may serve as the medical monitor for clinical trials as necessary.

In line with its seniority, the EMD is typically responsible for multiple clinical development programs in a therapeutic area spanning IND to POC/Phase 2/3 under the supervision of a VP Clinical Development TA Head. In addition, she/he may also have responsibility for discrete, specific business development efforts (e.g., a due diligence on a specific target) and keep close ties with the Discovery and Research organizations.

This position offers substantial opportunities for scientific and commercial interactions and career advancement in the fast-moving area of rare disease.

• Typically leading 2 program teams and drive the successful execution of clinical studies / programs / research strategies; define and manage the benefit to risk profile of our products
• Representing Clinical Development on the Global Program Team (GPT) and Global Medicine Team in presentations at management and review committees (e.g., Clinical Document Review Committee, Development and Commercial Steering Committee); advance understanding of the impact our therapies have on the pathophysiology of rare and orphan diseases through scientific discourse and interpretation of data
• Fostering development of Medical Directors and CDS and/or fellows. Lead and oversee 2 programs and the preparation and execution of a clinical development strategy and related documents including protocols, charters, statistical summary reports, meeting presentations, publications, and clinical sections of regulatory documents.
• Providing scientific and medical input (consultative services) to other R&D, commercial, translational, medicine and business development functions and leads and or oversees clinical activities to support due diligences
• Representing Alexion Clinical Development to internal (R&D management, cross functional development teams and executive committee) and external (academic, regulatory, and medical) communities.
• Overseeing a cross functional team which develops the clinical components of the CDP. Serve as the Clinical input to Global Development Team / Subteams and medical expert for the clinical study team. Oversees the writing of the clinical sections of the CTD, white papers, expert opinion reports, and regulatory responses
• Liaising internally with other members of the CDP to drive program strategy and CDPs. Coordinate communications and planning bet medical functions (Global Medical Affairs, Safety, Clinical Operations, Biostatistics, Epidemiology and Medical Science) as it relates to clinical development study design, execution and interpretation of results. Serves as the medical expert on the global product labeling team
• Driving awareness of internal and external developments (scientific, clinical, competitive, and regulatory) that could impact the development plan, including attendance at major scientific conferences, participation in competitive intelligence…